Twist Bioscience Corporation, a company enabling customers to
succeed through its offering of high-quality synthetic DNA, today
announced that the company has expanded its presence in Asia
Pacific, adding strategic distribution partners for synthetic DNA
(genes, gene fragment, oligo pool product lines) as well as the
exome and custom target enrichment product suite for
next-generation sequencing.
“The synthetic biology and next-generation sequencing markets
are growing rapidly in Asia Pacific, and we are now poised to serve
customers in Japan, Korea, India and Hong Kong,” said Emily M.
Leproust, Ph.D., CEO of Twist Bioscience. “Building on our solid
foundation in the United States and Europe, we are extending our
global footprint by leveraging selected distributors with strong
commercial presence and deep ties to our potential customers in
these important geographies.”
Related to this expansion, Twist Bioscience has entered into
distribution agreements with Recenttec K.K. in Japan; DNA Link and
its subsidiary LnCBio Inc. in Korea; Premas Life Sciences in India;
and, BioArrow Technology Limited in Hong Kong and Macau. Each
organization will be responsible for distributing Twist
Bioscience’s products in their respective geographies.
Recenttec K.K. Selected as Twist Bioscience’s Distribution
Partner for Japan
Recenttec K.K. is a company based in Tokyo, Japan that provides
products made in Taiwan, Europe and the U.S. including research
reagents, equipment and consumables to the life science research
market. Through alliances with industry leaders, Recenttec K.K.
aims to expand sales in the Japanese market, extend customer
satisfaction and become a valuable partner.
“In Japan, our life sciences customers value tools that allow
them to conduct their research more efficiently,” said Takashi
Hirahara, CEO of Recenttec. “We look forward to improving research
and development efforts in the Japanese marketplace by bringing
synthetic DNA products made using Twist Bioscience’s innovative
platform to the market.”
LnCBio Inc., Subsidiary of DNA Link Inc., Selected as Twist
Bioscience’s Distribution Partner for South Korea
Established in 2007, LnCBio Inc. has been supplying world
leading instruments, consumables and service to molecular research
and diagnostics market. With 10 years of excellent business
performance and qualified technical support, LnCBio Inc. is one of
the leading distributor companies in the biotechnology field in
South Korea. LnCBio Inc. is a subsidiary of DNA Link Inc., a
genomics service provider based in South Korea. Since its
establishment in 2000, DNA Link has participated in numerous
government/academia-sponsored research projects and became one of
the main players in the genomics field. Recently, DNA Link is
expanding its business area to precision medicine with
patient-derived xenograft service, non-invasive prenatal testing
service, and prognostic/predictive diagnostic test services for
early stage breast cancer patients, preparing to take a leap
forward from a service provider to precision medicine healthcare
expert.
“We have been serving the synthetic biology and next-generation
sequencing market for more than 15 years, with trusted
relationships across South Korea,” stated Dr. Jong Eun Lee, CEO of
DNA Link. “We look forward to offering Twist Bioscience’s suite of
improved solutions for multiple market opportunities to customers
we’ve served reliably for many years.”
BioArrow Technology Limited Selected as Twist Bioscience’s
Distribution Partner for Hong Kong and Macau
BioArrow Technology Limited was established in Hong Kong in
2017. Its primary focused region is Hong Kong and Macau. The
shareholders and top management team have shared the same core
values in many aspects in the business areas of life sciences and
clinical diagnostics. BioArrow uses professionals to serve
professionals with integrity and trust, with a strong team
consisting of expertise in molecular biology to support business in
genomic research, molecular diagnostics and other related
developing fields.
“We are confident that with the committed team and supportive
business partners, BioArrow Technology Limited will grow into
further success in the life sciences and clinical diagnostics with
Twist Bioscience Corporation,” commented Alson Yang, Director of
BioArrow Technology.
Premas Lifesciences Selected as Twist Bioscience’s
Distribution Partner for India
Premas Lifesciences is a knowledge driven boutique partner for a
range of specialized technologies in the field of life science,
genomics, cell biology, bio banking and other related applications.
The company prides itself in establishing concepts in the nascent
markets which became industry norm.
“Partnering with rapidly-growing companies to expand their reach
within India is our specialty at Premas Lifesciences, and we look
forward to bringing the power of synthetic biology to India to fuel
new and differentiated research in a timely fashion,” said Praveen
Gupta, managing director of Premas.
About Twist Bioscience Corporation
At Twist Bioscience Corporation, we work in service of customers
who are changing the world for the better. In fields such as health
care, agriculture, industrial chemicals, academic research and data
storage, by using our synthetic DNA tools, our customers are
developing ways to better lives and improve the sustainability of
the planet. We believe that the faster our customers succeed, the
better for all of us, and we believe Twist Bioscience is uniquely
positioned to help accelerate their efforts.
Our innovative silicon-based DNA synthesis platform provides
precision at a scale that we believe is otherwise unavailable to
our customers. Our platform technologies overcome inefficiencies
and enable cost-effective, rapid, precise, high-throughput
synthesis and sequencing, providing both the quality and quantity
of the tools they need to rapidly realize the opportunity ahead.
For more information about our products and services, please visit
www.twistbioscience.com. Twist Bioscience is on Twitter. Sign up to
follow our Twitter feed @TwistBioscience at
https://twitter.com/TwistBioscience.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180417005589/en/
Investor Contact:Argot PartnersMaeve Conneighton,
212-600-1902maeve@argotpartners.comorMedia Contact:Angela Bitting,
925-202-6211media@twistbioscience.com